Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes
Publication
, Conference
Granger, CB; Diener, H-C; Sacco, RL; Easton, JD; Cronin, L; Fraessdorf, M; Grauer, C; Brueckmann, M
Published in: CIRCULATION
December 18, 2018
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E768 / E768
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Granger, C. B., Diener, H.-C., Sacco, R. L., Easton, J. D., Cronin, L., Fraessdorf, M., … Brueckmann, M. (2018). Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes. In CIRCULATION (Vol. 138, pp. E768–E768). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
Granger, Christopher B., Hans-Christoph Diener, Ralph L. Sacco, J Donald Easton, Lisa Cronin, Mandy Fraessdorf, Claudia Grauer, and Martina Brueckmann. “Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes.” In CIRCULATION, 138:E768–E768. LIPPINCOTT WILLIAMS & WILKINS, 2018.
Granger CB, Diener H-C, Sacco RL, Easton JD, Cronin L, Fraessdorf M, et al. Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E768–E768.
Granger, Christopher B., et al. “Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes.” CIRCULATION, vol. 138, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2018, pp. E768–E768.
Granger CB, Diener H-C, Sacco RL, Easton JD, Cronin L, Fraessdorf M, Grauer C, Brueckmann M. Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus): Arrhythmia Monitoring And Outcomes. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2018. p. E768–E768.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 18, 2018
Volume
138
Issue
25
Start / End Page
E768 / E768
Location
Chicago, IL
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology